The enteral feeding devices market in the Middle East and Africa was worth USD 0.18 billion in 2022 and is estimated to grow at a CAGR of 4.19% and reach USD 0.22 billion by 2027. Enteral nutrition is growingly being accepted as an effective system of clinical nutrition.
A shift in the MEA enteral feeding market from routine hospital care to home setting/non-clinical enteral nutrition is increasing and has been significant in the healthcare sector. The rising costs of hospital stays have often forced clinicians involved in patients requiring nutritional support for long periods to encourage patients to adopt enteral nutrition at home. Several countries, such as UAE, Bahrain, Turkey, and Egypt, have established nutrition teams that support patients receiving enteral nutrition at home. Therefore, the demand for enteral nutrition positively impacts the MEA market, and this shift is seen in the developed countries of the MEA.
According to the United Nations Department of Economic and Social Affairs, an estimated 12.7% of the world's population was aged in 2014. Aged people are much more likely to get diagnosed with diabetes, vascular disease, stroke, cancer, dementia, arthritis, osteoporosis, circulatory failure, and Parkinson's disease. Therefore, the usage of enteral feeding devices is more among the aged people suffering from the above-mentioned diseases. In MEA, a considerable amount of aged people are suffering from various diseases, which is expected to result in regional market growth. Furthermore, the rising adoption of technological developments in manufacturing effective enteral feeding devices across the MEA regions are expected to boost the growth rate of the MEA market.
However, factors such as insufficient reimbursement issues for enteral feeding in most developing countries in the Middle East and Africa hamper the market growth in this region. In addition, declining federal funding and subsequent reductions in reimbursements for home care services are other notable factors hindering the regional market growth.
This research report on the Middle East and Africa enteral feeding devices market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
The enteral feeding devices market in the African region is estimated to hold a major share of the MEA market during the forecast period. The market growth in this region is majorly driven by the growing aging population, rising awareness of enteral nutrition, increasing incidence of premature births, the rapid development of healthcare facilities, and others. As a result, major players have turned to emerge economies in these regions.
Besides, the players in the Middle East market are more effectively dominating the growth of the market while bringing significant developments in the techniques of manufacturing products and the method of performing the task, further increasing the demand and leading to the growth of the market in more effective over the years to come. Therefore, many Middle East countries are expected to have good lucrative growth opportunities in the forecasted period.
KEY MARKET PLAYERS:
Companies playing a major role in the MEA enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org